Vitamin K for Masld

Verdict: Unproven for fatty liver disease

There is not enough evidence to say vitamin K treats MASLD (metabolic dysfunction-associated steatotic liver disease). The only human data are observational and cannot show cause and effect, so vitamin K should not be used as a therapy for fatty liver.

U ⚫ U Unverified Insufficient Evidence

🔬Why this grade7-layer evidence engine

This claim is rated Unverified because the evidence sits at the lowest tier. No randomized controlled trials, Cochrane reviews, or meta-analyses have tested whether vitamin K improves MASLD. The strongest human data are two NHANES population studies: a 2025 prospective cohort of 7,857 NAFLD patients linking higher dietary vitamin K to lower all-cause mortality with a threshold near 121 mcg/day (PMID 40456852), and a 2023 cross-sectional study (n=3,571) associating higher intake with lower MAFLD risk (PMID 37305083). A 2024 mouse study suggests vitamin K2 protects against diet-induced fatty liver (PMID 38321064).

Observational signals like these cannot prove causation. People who eat more vitamin K (leafy greens) tend to have healthier diets overall, and the 121 mcg/day threshold roughly matches the adult adequate intake, so the finding may simply reflect generally healthier eaters rather than a treatment effect of the vitamin itself.

Regulators and clinics back this caution. The FDA, EFSA, NHS, and WHO authorize vitamin K only for blood clotting, bone maintenance, and newborn bleeding prophylaxis, not for liver disease. Mayo Clinic, Cleveland Clinic, Harvard Health, and the AASLD and EASL liver-disease guidelines do not list vitamin K for MASLD; Mayo even notes liver disease may raise the risk of side effects. Anyone on warfarin should keep vitamin K intake steady, as supplements can interfere with the drug.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.57
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
U · Insufficient Evidence
Confidence
82%
Highly consistent evidence
Evidence level
E8
Cohort / observational

How strongly each layer supports this effect

lower = less supportive
L1 ExamineGlobal benchmark
0.50
L3 MechanismPlausibility
0.50
L11 AI re-checkIndependent read
0.50
L5 Clinical bodiesAuthoritative stance
0.55
L2 PubMedPrimary literature
0.70
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.573
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 僅有 E8 級證據 (cohort/animal/mechanism),不足以下結論
  4. apply_hec_override — HEC-4 僅低階證據 (E8-E10) — 強制由 B 改為 U
  5. tier_strict_requirement_check — Tier 條件達標,未降階
  6. detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
  7. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (3)L2 · primary research & systematic reviews

Dietary vitamin K intake associates with reduced all-cause mortality in non-alcoholic fatty liver disease patients
PMID: 40456852 2025 Cohort
— See PubMed for details
View on PubMed
The relationship between vitamin K and metabolic dysfunction-associated fatty liver disease among the United States population: NHANES 2017–2018
PMID: 37305083 2023 Cross-sectional
— See PubMed for details
View on PubMed
Vitamin K2 protects mice against non-alcoholic fatty liver disease induced by high-fat diet
PMID: 38321064 2024 Animal Study
— See PubMed for details
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Supportive
Vitamin K1 Injection is indicated for prophylaxis and treatment of vitamin K-deficiency bleeding in neonates source↗
L4b EU EFSA
Supportive
a cause and effect relationship has been established between the dietary intake of vitamin K and normal blood coagulation ... and the maintenance of normal bone source↗
L4c UK NHS
Cautious
You should be able to get all the vitamin K you need by eating a varied and balanced diet. Any vitamin K your body does not need immediately is stored in the liver for future use, so you do not need it in your diet every day. source↗
L4d TW TFDA / 衛福部
Supportive
成年男性 120 微克/日,女性 90 微克/日(足夠攝取量 AI) source↗
L4e WHO
Supportive
vitamin K1 should be given to all newborns as a single, intramuscular dose of 0.5–1 mg source↗
L5a NIH Office of Dietary Supplements
Supportive
Vitamin K, the generic name for a family of compounds with a common chemical structure of 2-methyl-1,4-naphthoquinone, is a fat-soluble vitamin source↗
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬3 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-masld-INT-vitamin-k-001 繁體中文版 →